Panion
  • Home
  • Our Story
    • History
    • Board
  • Science
    • Epilepsy in dogs
    • About Gene therapy
    • About NPY and AAV vectors
  • News
  • Investor relations
Select Page

DRA contract ends & New advisory board member

Jan 19, 2018

Panion Animal Health AB’s Director Regulatory Affairs, Niels-Erik Manniche, has decided to leave the company. Panion’s advisory board has been expanded with Dr. Curtis W. Dewey from Cornell University, New York. Read more...

Article in Investerarbrevet.se

Jan 11, 2018

Only in Swedish >>

Panion enters into SEK 9,5 million financing and receives SEK 3 million in first tranche financing

Jan 9, 2018

Read more >>

Panion’s epilepsy product candidate for gene therapy in the dog: FDA has established an Investigational New Animal Drug (INAD) file.

Jan 3, 2018

Read more >>

Archives

  • April 2020
  • March 2020
  • February 2020
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • June 2016
  • May 2016
  • February 2016
  • August 2015
  • July 2015

Panion Animal Health AB

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.